Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Neurology. 2004 Nov 9;63(9):1705-7.

    Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial.

    Source

    Department of Psychiatry, University of California, San Francisco, and San Francisco VA Medical Center, CA, USA.

    Abstract

    Participants in the Age-Related Eye Disease Study were randomly assigned to receive daily antioxidants (vitamin C, 500 mg; vitamin E, 400 IU; beta carotene, 15 mg), zinc and copper (zinc, 80 mg; cupric oxide, 2 mg), antioxidants plus zinc and copper, or placebo. A cognitive battery was administered to 2,166 elderly persons after a median of 6.9 years of treatment. Treatment groups did not differ on any of the six cognitive tests (p > 0.05 for all). These results do not support a beneficial or harmful effect of antioxidants or zinc and copper on cognition in older adults.

    PMID:
    15534261
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1473037
    Free PMC Article

    Images from this publication.See all images (1)Free text

    Figure

      Supplemental Content

      Icon for HighWire Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk